Araz M - Search Results

1

Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer.

Yıldız O, Gürbüz AF, Karakurt Eryılmaz M, Araz M, Aykut T, Şahin Ö, Büyükboyacı NH, Çelik Z, Artaç M. Yıldız O, et al. Among authors: araz m. J Oncol Pharm Pract. 2024 Sep 23:10781552241276191. doi: 10.1177/10781552241276191. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 39311109 Free article.

2

Small bowel wall edema induced by regorafenib is associated with regorafenib intolerance and shorter survival in patients with metastatic colorectal cancer: A retrospective study.

Karakurt Eryılmaz M, Kerimoğlu Ü, Karaağaç M, Yalçın Müsri F, Araz M, Artaç M. Karakurt Eryılmaz M, et al. Among authors: araz m. J Oncol Pharm Pract. 2021 Dec;27(8):1929-1935. doi: 10.1177/1078155220978471. Epub 2020 Dec 6. J Oncol Pharm Pract. 2021. PMID: 33283629

3

Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer.

Uğraklı M, Araz M, Demirkıran A, Çelik AF, Karakurt Eryılmaz M, Karaağaç M, Artaç M. Uğraklı M, et al. Among authors: araz m. J Oncol Pharm Pract. 2022 Apr;28(3):740-745. doi: 10.1177/10781552211066073. Epub 2021 Dec 22. J Oncol Pharm Pract. 2022. PMID: 34935553

4

A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy.

Hendem E, Korkmaz M, Uğraklı M, Karakurt Eryılmaz M, Karaağaç M, Araz M, Artaç M. Hendem E, et al. Among authors: araz m. J Oncol Pharm Pract. 2022 Jul;28(5):1222-1225. doi: 10.1177/10781552221074046. Epub 2022 Jan 19. J Oncol Pharm Pract. 2022. PMID: 35044279

5

Ribociclib-induced hepatotoxicity.

Er MM, Araz M, Hendem E, Eryılmaz MK, Artaç M. Er MM, et al. Among authors: araz m. J Oncol Pharm Pract. 2023 Jul;29(5):1275-1277. doi: 10.1177/10781552231154009. Epub 2023 Feb 10. J Oncol Pharm Pract. 2023. PMID: 36762416

6

Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report.

Gürbüz AF, Eryılmaz MK, Yıldız O, Kaya BE, Araz M, Artaç M. Gürbüz AF, et al. Among authors: araz m. J Oncol Pharm Pract. 2024 Aug 14:10781552241271791. doi: 10.1177/10781552241271791. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 39140806 Free article.

7

The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort.

Karaağaç M, Sezgin Y, Eryılmaz MK, Araz M, Kaplan MA, Artaç M. Karaağaç M, et al. Among authors: araz m. J Oncol Pharm Pract. 2020 Oct;26(7):1657-1666. doi: 10.1177/1078155220904138. Epub 2020 Feb 17. J Oncol Pharm Pract. 2020. PMID: 32063110

8

Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.

Korkmaz M, Eryılmaz MK, Karaağaç M, Demirkıran A, Araz M, Artaç M. Korkmaz M, et al. Among authors: araz m. J Oncol Pharm Pract. 2021 Jul;27(5):1307-1310. doi: 10.1177/1078155220963178. Epub 2020 Oct 7. J Oncol Pharm Pract. 2021. PMID: 33028131

9

Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor.

Er MM, Araz M, Karabacak M, Uğraklı M, Eryılmaz MK, Karaağaç M, Artaç M. Er MM, et al. Among authors: araz m. J Oncol Pharm Pract. 2021 Dec;27(8):2049-2052. doi: 10.1177/10781552211016081. Epub 2021 May 12. J Oncol Pharm Pract. 2021. PMID: 33977817

10

Immunotherapy era in the treatment of small cell lung cancer.

Araz M, Karakurt Eryilmaz M. Araz M, et al. Med Oncol. 2021 Jun 22;38(7):86. doi: 10.1007/s12032-021-01535-5. Med Oncol. 2021. PMID: 34156575 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters